IDEAYA Biosciences, Inc.

IDYA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$274-$113-$59-$50
Dep. & Amort.$4$4$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$35$18$12$8
Change in WC$12-$13-$42-$18
Other Non-Cash-$23-$12-$1$2
Operating Cash Flow-$248-$115-$87-$56
Investing Activities
PP&E Inv.-$4-$2-$3-$3
Net Acquisitions$0$0$33$67
Inv. Purchases-$1,191-$596-$256-$315
Inv. Sales/Matur.$693$440$226$248
Other Inv. Act.$0$0-$33-$67
Investing Cash Flow-$503-$158-$33-$70
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$654$310$95$143
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$23$53$2$2
Financing Cash Flow$678$363$97$145
Forex Effect$0$0$0$0
Net Chg. in Cash-$73$89-$23$20
Supplemental Information
Beg. Cash$158$69$92$72
End Cash$85$158$69$92
Free Cash Flow-$251-$118-$91-$58